Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–6 of 6 stories
Eli Lilly reported $19.3 billion in revenue for Q4 and is expanding its GLP-1 franchise into immunology and inflammation. Ongoing trials target asthma, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
The National Institute of Arthritis and Musculoskeletal and Skin Diseases has announced a partially closed meeting. This meeting will discuss ongoing research and initiatives related to arthritis and musculoskeletal diseases.
A new CDC study reveals that arthritis significantly affects African-Americans and Hispanics more than whites, leading to increased pain and limitations. This highlights the need for targeted interventions in these communities.
A CDC study reveals that arthritis can hinder physical activity in individuals with heart disease, potentially complicating their management. This finding highlights the need for integrated care approaches addressing both conditions.
A new CDC study reveals that over 50% of adults with diabetes also suffer from arthritis, which hinders their ability to engage in physical activity crucial for diabetes management. This highlights the need for integrated care strategies addressing both conditions.
The CDC reports that work limitations due to arthritis affect 3.4% of adults in Hawaii and up to 15% in Kentucky, highlighting significant regional disparities. This first-ever state-by-state data underscores the need for targeted interventions in affected areas.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.